Istradefylline
Last Updated: 06/30/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 296 publications
Adenosine A2A receptors in the chorioid plexus are causal in mediating the development of hydrocephalus.
Journal: Purinergic signalling
Published: March 15, 2026
Early neural shift detection using functional magnetic resonance imaging: a pilot study with Parkinson's disease patients undergoing istradefylline and hybrid assistive limb interventions.
Journal: Frontiers in neurology
Published: February 24, 2026
Expanding Clinical Experience With Istradefylline in ADCY5-Related Movement Disorder: A Case With No Benefit.
Journal: Movement disorders clinical practice
Published: February 02, 2026
Purinergic modulation in Parkinson's disease: the dual role of istradefylline in motor and cognitive outcomes.
Journal: Purinergic signalling
Published: February 02, 2026
Dual CD73/A2AR blockade modulates the neurotoxic astrocyte phenotype without disrupting core inflammatory signaling.
Journal: Frontiers in pharmacology
Published: December 30, 2025
Caffeine Mitigates Adenosine-Mediated Angiogenic Properties of Choroidal Endothelial Cells Through Antagonism of A1 Adenosine Receptor and PI3K-AKT Axis.
Journal: Cells
Published: December 10, 2025
High-throughput screening for the discovery of antidepressants targeting adenosine A2A receptors.
Journal: Bioorganic chemistry
Published: November 26, 2025
Adenosine A₂A receptor as a dual-acting molecular switch: Glial morphological changes and neurovascular tissue remodeling in neuroinflammation and neurodegeneration.
Journal: Tissue & cell
Published: November 24, 2025
Involvement of Adenosine A2A Receptors in Anxiety-Like Behaviors in Tetrahydrocannabinol-Treated Mice.
Journal: Brain and behavior
Published: November 18, 2025
Human Neuraminidase 3 reduces the severity of Tay-Sachs disease symptoms in a mouse model.
Journal: Neurochemistry international
Published: November 17, 2025
Long-term outcomes associated with istradefylline versus catechol-O-methyltransferase inhibitors in patients with Parkinson's disease: a nationwide real-world cohort study.
Journal: Parkinsonism & related disorders
Published: October 28, 2025
Treatment strategies for motor fluctuations in Parkinson's disease: a systematic review of efficacy, functionality, and drug accessibility with a focus on Latin America.
Journal: Frontiers in pharmacology
Published: October 14, 2025
Last Updated: 06/30/2026